Ergoteles LLC Vericel Corp Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$23.85 - $31.34 $1.55 Million - $2.03 Million	64,800 New	64,800 $1.9 Million
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $843,768 - $1.45 Million	-36,878 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$31.69 - $43.29 $284,354 - $388,441	8,973 Added 32.16%	36,878 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $982,256 - $1.47 Million	27,905 New	27,905 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $482,040 - $621,400	-10,400 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$47.2 - $67.81 $490,880 - $705,224	10,400 New	10,400 $546,000

279

48.7M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.